Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study: 2016; 3:. Published Online http://dx.doi.org/10.1016/S2352-3018 (16) 30011-X

Citation:

20. Alberto ML, L.H.J. & for Babafemi Taiwo, Carole L Wallis, L.Z.P.K.K.M.H.B.J.J.M.A.C.A.C.T.G.S.N.C.W., 2016. Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study: 2016; 3:. Published Online http://dx.doi.org/10.1016/S2352-3018 (16) 30011-X. Lancet HIV, 3, p.247–58.